- Raised $4M Seed round led by Aurum Ventures M.K.I, Oct 2018
About
LIVEKIDNEY.BIO is a regenerative medicine, clinical-stage company focused on improving the health span and lifespan for kidney patients worldwide. The company's products are based on proprietary, cell-shielding formulations of mesenchymal stromal cells (MSCs) that promote the continuous release of therapeutic bioactive compounds. These products aim to address major hallmarks of aging, modulating the immune system, reducing inflammation and fibrosis, and improving mitochondrial activity, thereby improving kidney function. Their technology utilizes a proprietary delivery platform with biodegradable hydrogel formulations for cell therapies, aiming to halt the progression of kidney disease towards kidney failure and address associated comorbidities.
Funding history · 1 round · $4.0M total
Headcount over time
Q&A
- What is LIVEKIDNEY.BIO's primary focus?
- LIVEKIDNEY.BIO is a clinical-stage biotech company developing cell-based therapies for kidney diseases, aiming to improve the health span and lifespan for kidney patients worldwide.
- When was LIVEKIDNEY.BIO founded?
- LIVEKIDNEY.BIO was founded in 2013.
- What is LIVEKIDNEY.BIO's employee count?
- LIVEKIDNEY.BIO has 1-10 employees.
- What is the total amount of funding LIVEKIDNEY.BIO has raised to date?
- LIVEKIDNEY.BIO has raised a total of $9,000,000 USD.
- When did LIVEKIDNEY.BIO complete its most recent funding round?
- LIVEKIDNEY.BIO completed a Seed funding round in November 2023, raising $4,000,000 USD.
- What technology does LIVEKIDNEY.BIO utilize in its products?
- LIVEKIDNEY.BIO's products are based on proprietary, cell-shielding formulations of mesenchymal stromal cells (MSCs) and utilize a proprietary delivery platform with biodegradable hydrogel formulations for cell therapies, combined with AI-enabled data analytics.
- What is the current product stage of LIVEKIDNEY.BIO?
- LIVEKIDNEY.BIO is in the clinical trial product stage.
- Who is the CEO and Co-Founder of LIVEKIDNEY.BIO?
- Alon Yaar is the CEO and Co-Founder of LIVEKIDNEY.BIO.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | livekidney.bio/ |
|---|
Identifiers & details
| Legal name | Livekidney.Bio Ltd. |
|---|---|
| Former names | KidneyCure |
| Founded | 2013 |
| Employees (exact) | 8 |
Radar intelligence
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | livekidney.bio |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514345578 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2009-11-17 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 2 — annual_report (2) |
| Registered address | אחד העם 9 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-02 | דו~ח שנתי-עדכון מען דיגיטלי |
| 2026-06-02 | דו~ח שנתי-הקצאת מניות |